Pubblicazioni

Improving the Nuclear-Localized Androgen Receptor Splice Variant 7 Test

2019 - JAMA ONCOLOGY

Nicolazzo, Chiara; Gradilone, Angela; Gazzaniga, Paola

Paclitaxel and Alisertib in recurrent ovarian cancer

2019 - JAMA ONCOLOGY

Tomao, F.; Benedetti Panici, P.; Tomao, S.

Survival outcomes in patients with previously untreated BRAF wild-type advanced melanoma treated with nivolumab therapy. three-year follow-up of a randomized phase 3 trial

2019 - JAMA ONCOLOGY

Ascierto, P. A.; Long, G. V.; Robert, C.; Brady, B.; Dutriaux, C.; Di Giacomo, A. M.; Mortier, L.; Hassel, J. C.; Rutkowski, P.; Mcneil, C.; Kalinka-Warzocha, E.; Savage, K. J.; Hernberg, M. M.; Lebbe, C.; Charles, J.; Mihalcioiu, C.; Chiarion-Sileni, V.; Mauch, C.; Cognetti, F.; Ny, L.; Arance, A.; Svane, I. M.; Schadendorf, D.; Gogas, H.; Saci, A.; Jiang, J.; Rizzo, J.; Atkinson, V.

Improving the Nuclear-Localized Androgen Receptor Splice Variant 7 Test

2019 - JAMA ONCOLOGY

Nicolazzo, C.; Gradilone, A.; Gazzaniga, P.

Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan A Phase 2 Single-Arm Clinical Trial

2019 - JAMA ONCOLOGY

Cremolini, C; Rossini, D; Dell'Aquila, E; Lonardi, S; Conca, E; Del Re, M; Busico, A; Pietrantonio, F; Danesi, R; Aprile, G; Tamburini, E; Barone, C; Masi, G; Pantano, F; Pucci, F; Corsi, Dc; Pella, N; Bergamo, F; Rofi, E; Barbara, C; Falcone, A; Santini, D